AFMDQ (Affimed NV) Beneish M-Score: 0.00 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AFMDQ Affimed NV AFMDQ
16 GF Score
Price $0.00
View Full Analysis

What is Affimed NV Beneish M-Score?

Affimed NV AFMDQ 16 Beneish M-Score is 0.00 as of Jul. 30, 2026. GuruFocus rates AFMDQ with a GF Score™ of 16/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Affimed NV's Beneish M-Score or its related term are showing as below:

During the past 12 years, the highest Beneish M-Score of Affimed NV was 0.00. The lowest was 0.00. And the median was 0.00.

Affimed NV Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Affimed NV's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Affimed NV Beneish M-Score Chart

Affimed NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -1.10 -1.62 -2.98 4.44

Affimed NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.55 4.44 8.76 22.11 31.11

AFMDQ vs SYRS, BTAX, TRVN: Beneish M-Score Comparison

For the Biotechnology subindustry, Affimed NV's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affimed NV Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affimed NV's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Affimed NV's Beneish M-Score falls into.


AFMDQ
16GF Score
Affimed NV AFMDQ
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Affimed NV Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Affimed NV for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 40.9175+0.528 * 1+0.404 * 1.1199+0.892 * 0.0472+0.115 * 0.6031
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 15.159+4.679 * 0.072289-0.327 * 1.5804
=31.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was $5.04 Mil.
Revenue was 0.172 + 0.166 + 0.168 + 0.45 = $0.96 Mil.
Gross Profit was 0.172 + 0.166 + 0.168 + 0.45 = $0.96 Mil.
Total Current Assets was $35.95 Mil.
Total Assets was $44.35 Mil.
Property, Plant and Equipment(Net PPE) was $8.38 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.73 Mil.
Selling, General, & Admin. Expense(SGA) was $20.72 Mil.
Total Current Liabilities was $18.62 Mil.
Long-Term Debt & Capital Lease Obligation was $6.64 Mil.
Net Income was -16.802 + -16.632 + -20.842 + -22.034 = $-76.31 Mil.
Non Operating Income was -0.831 + 0.236 + 0.565 + 4.277 = $4.25 Mil.
Cash Flow from Operations was -12.358 + -17.771 + -25.889 + -27.745 = $-83.76 Mil.
 Total Receivables was $2.61 Mil.
Revenue was 2.094 + 1.506 + 4.829 + 11.82 = $20.25 Mil.
Gross Profit was 2.094 + 1.506 + 4.829 + 11.82 = $20.25 Mil.
Total Current Assets was $114.01 Mil.
Total Assets was $128.56 Mil.
Property, Plant and Equipment(Net PPE) was $14.51 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.31 Mil.
Selling, General, & Admin. Expense(SGA) was $28.95 Mil.
Total Current Liabilities was $30.83 Mil.
Long-Term Debt & Capital Lease Obligation was $15.52 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.042 / 0.956) / (2.61 / 20.249)
=5.274059 / 0.128895
=40.9175

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(20.249 / 20.249) / (0.956 / 0.956)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (35.95 + 8.383) / 44.35) / (1 - (114.012 + 14.508) / 128.564)
=0.000383 / 0.000342
=1.1199

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.956 / 20.249
=0.0472

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.306 / (3.306 + 14.508)) / (3.726 / (3.726 + 8.383))
=0.185584 / 0.307705
=0.6031

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20.72 / 0.956) / (28.951 / 20.249)
=21.67364 / 1.42975
=15.159

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6.644 + 18.622) / 44.35) / ((15.515 + 30.829) / 128.564)
=0.569696 / 0.360474
=1.5804

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-76.31 - 4.247 - -83.763) / 44.35
=0.072289

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Affimed NV has a M-score of 31.11 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
Affimed NV (AFMDQ) has a Beneish M-Score of 0.00 as of Jul. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Affimed NV and its competitors.
Is Affimed NV's Beneish M-Score too high?
Affimed NV's current Beneish M-Score is 0.00. Overall, Affimed NV has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Affimed NV's Beneish M-Score compare to SYRS and BTAX?
Affimed NV's Beneish M-Score of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Affimed NV and its competitors. Affimed NV's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Affimed NV stock overvalued right now?
Affimed NV (AFMDQ) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Affimed NV's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Affimed NV (AFMDQ), the current Beneish M-Score is 0.00 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Affimed NV Business Description

Address Gottlieb-Daimler-Strabe 2, Mannheim, BW, DEU, 68165
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.
16GF Score

Get the complete analysis for AFMDQ

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price